1 / 11

Vanadis Capital unique offer:

”We aim to be the preferred life sciences investment company in Northern Europe…” “We have the people, the differentiation, the mind-set, and the structure to deliver better investment returns…” . Vanadis Capital unique offer: .

tatum
Télécharger la présentation

Vanadis Capital unique offer:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ”We aim to be the preferred life sciences investment company in Northern Europe…”“We have the people, the differentiation, the mind-set, and the structure to deliver better investment returns…”

  2. Vanadis Capitalunique offer: • Partnership with TFS International, the largest private and independent clinical research organization (CRO) in Europe • Team experience and background is aligned with business demands, fund management, and exit opportunities • Small size fund by design and strongly committed GP • Already screened and identified investment opportunities to bring momentum to the investment cycle right after first close

  3. Complementary, unique, and differentiated deal flow from exclusive TFS partnership • 400+ potential target companies across Europe • Pre-validate by TFS management according to Vanadis Capital investment criteria • 40% within the Nordic region • 50% are either medtech, diagnostics, or medical services companies

  4. “Getting the right mix of people in the team is a determinant factor to our future success as a venture firm, our competences and capabilities all put together contribute to what makes Vanadis Capital very unique and well set to deliver strong returns”

  5. Unique mix of competences and capabilities

  6. A smaller fund is advantageous compared to larger funds: • Better alignment between the GP and LP incentives • Better leverage on specialized industry expertise • Opportunity to complement larger funds at good financial conditions • Needs fewer home runs to secure high fund returns Source: Silicon Valley Bank, VC reportmay 2010

  7. Vanadis Capital partners are strongly committed and aligned with LP incentives • GP commitment @ 6% of the fund • Cap on management fees with a focus to operate with predictable fixed costs • Transparency on GP budget • Readiness to offer deal on carries provided that GP incentives remain solid

  8. Identified Investment Opportunities

  9. Vanadis value creation summary • Accelerate product development • Accelerate product adoption • Strategic and operational expertise • Management reviews (including staffing) • Well prepared and executed exits

  10. Conclusion Vanadis Capital has access to a unique pre-validated and differentiated deal flow Vanadis Capital team is competent, experienced, and strongly committed Vanadis Capital has a unique opportunity to create value in life sciences for the benefit of patients, society, and its investors!

More Related